Table 2.
Comparison of Laboratory Parameters Between the Survivor and Non-Survivor of COVID-19 Patients
| Survivor | Non-Survivor | P value | |
|---|---|---|---|
| WBC, ×109/L | 4.7 (3.6–6.0) | 13.0 (7.8–17.8) | <0.001 |
| Lymphocytes, ×109/L | 1.1 (0.8–1.5) | 0.6 (0.4–0.7) | <0.001 |
| Neutrophils, ×109/L | 3.0 (2.2–3.8) | 11.6 (6.9–16.6) | <0.001 |
| CRP, mg/L | 15.7 (4.5–35.3) | 76.7 (36.8–229.0) | <0.001 |
| TC/HDL-c ratio | 4.5 (3.8–5.6) | 5.0 (3.4–5.6) | 0.899 |
| LDL-c/HDL-c ratio | 3.2 (2.5–4.1) | 2.2 (1.4–3.4) | 0.010 |
| TG/HDL-c ratio | 1.4 (0.9–2.1) | 2.5 (1.5–4.8) | 0.001 |
Notes: P values indicate differences between survivor and non-survivor of COVID-19 patients. P<0.05 was considered statistically significant (marked in bold).
Abbreviations: COVID-19, Coronavirus disease 2019; WBC, White blood cells; CRP, C-reactive proteins; TC/HDL-c ratio, total cholesterol-to-high-density lipoprotein cholesterol ratio; LDL-c/HDL-c ratio, low-density lipoprotein cholesterol-to-high-density lipoprotein cholesterol ratio; TG/HDL-c ratio, triglyceride-to-high-density lipoprotein cholesterol ratio.